Efficacy and Safety of a Purified Standardised Bee Venom Preparation

Immunotherapy of Bee Venom Allergy: Evaluation of a New Purified Bee Venom Preparation in Comparison With Already Published Studies.

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00263952

Enrollment

Unknown

Registered

2005-12-12

Start date

2003-03-31

Completion date

2010-04-30

Last updated

2013-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bee Venom Allergy

Keywords

Bee venom allergy, Specific immunotherapy

Brief summary

The trial is performed to assess efficacy and safety of a purified standardised bee venom preparation in bee venom allergy

Interventions

BIOLOGICALbee venom

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* History of bee venom allergy, * Positive RAST for bee venom, * Positive skin prick test for bee venom

Exclusion criteria

* Serious chronic diseases

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026